X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Merck Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs MERCK LTD - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER MERCK LTD PFIZER/
MERCK LTD
 
P/E (TTM) x 24.6 26.8 91.6% View Chart
P/BV x 3.9 3.0 130.1% View Chart
Dividend Yield % 0.8 0.9 88.0%  

Financials

 PFIZER   MERCK LTD
EQUITY SHARE DATA
    PFIZER
Mar-16
MERCK LTD
Dec-16
PFIZER/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs2,7241,060 257.0%   
Low Rs1,611623 258.6%   
Sales per share (Unadj.) Rs440.9632.4 69.7%  
Earnings per share (Unadj.) Rs48.745.7 106.5%  
Cash flow per share (Unadj.) Rs75.862.3 121.6%  
Dividends per share (Unadj.) Rs15.0011.00 136.4%  
Dividend yield (eoy) %0.71.3 52.9%  
Book value per share (Unadj.) Rs462.9388.8 119.1%  
Shares outstanding (eoy) m45.7516.60 275.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.91.3 369.5%   
Avg P/E ratio x44.518.4 241.8%  
P/CF ratio (eoy) x28.613.5 211.8%  
Price / Book Value ratio x4.72.2 216.3%  
Dividend payout %30.824.1 128.0%   
Avg Mkt Cap Rs m99,16313,969 709.9%   
No. of employees `0002.91.6 182.5%   
Total wages/salary Rs m2,7581,487 185.5%   
Avg. sales/employee Rs Th6,981.76,631.9 105.3%   
Avg. wages/employee Rs Th954.5939.2 101.6%   
Avg. net profit/employee Rs Th771.1479.4 160.8%   
INCOME DATA
Net Sales Rs m20,17010,498 192.1%  
Other income Rs m857242 353.7%   
Total revenues Rs m21,02810,741 195.8%   
Gross profit Rs m4,3101,135 379.6%  
Depreciation Rs m1,239276 449.6%   
Interest Rs m50-   
Profit before tax Rs m3,9231,102 356.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,794343 522.7%   
Profit after tax Rs m2,228759 293.6%  
Gross profit margin %21.410.8 197.6%  
Effective tax rate %45.731.1 146.8%   
Net profit margin %11.07.2 152.8%  
BALANCE SHEET DATA
Current assets Rs m16,2996,410 254.3%   
Current liabilities Rs m7,5948,828 86.0%   
Net working cap to sales %43.2-23.0 -187.3%  
Current ratio x2.10.7 295.6%  
Inventory Days Days6558 113.2%  
Debtors Days Days2638 67.1%  
Net fixed assets Rs m8,6221,406 613.0%   
Share capital Rs m458166 275.6%   
"Free" reserves Rs m20,7226,286 329.7%   
Net worth Rs m21,1806,455 328.1%   
Long term debt Rs m250-   
Total assets Rs m29,1378,828 330.0%  
Interest coverage x755.5NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.71.2 58.2%   
Return on assets %7.78.6 89.2%  
Return on equity %10.511.8 89.5%  
Return on capital %19.017.1 111.2%  
Exports to sales %0.18.3 0.7%   
Imports to sales %17.521.0 83.1%   
Exports (fob) Rs m12869 1.4%   
Imports (cif) Rs m3,5262,209 159.6%   
Fx inflow Rs m52959 5.4%   
Fx outflow Rs m1402,612 5.4%   
Net fx Rs m-88-1,653 5.3%   
CASH FLOW
From Operations Rs m3,4361,070 321.0%  
From Investments Rs m-6,991-750 932.5%  
From Financial Activity Rs m-619-150 413.1%  
Net Cashflow Rs m-4,174171 -2,442.1%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 51.8 123.4%  
Indian inst/Mut Fund % 7.5 18.2 41.2%  
FIIs % 4.9 1.0 490.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 29.1 81.4%  
Shareholders   85,207 28,591 298.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   DR. DATSONS LABS  DISHMAN PHARMA  TTK HEALTHCARE  NATCO PHARMA  FRESENIUS KABI ONCO.  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Aug 23, 2017 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS